Finance

Beta
Ask
Lists
AFJK:NASDAQ
Aimei Health Technology Co Ltd
$35.00
0.00%
(0.00) 1D
Jun 15, 1:56:47 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AFJK...
Mkt. cap
110.82M
Avg. vol.
2.62K
Volume
3.00
P/E ratio
104.57
52-wk high
$130.37
52-wk low
$6.75
EPS
$0.33
Shares outstanding
3.17M
No. of employees
0
Mkt. cap
110.82M
Avg. vol.
2.62K
Volume
3.00
P/E ratio
104.57
52-wk high
$130.37
52-wk low
$6.75
EPS
$0.33
Shares outstanding
3.17M
No. of employees
0
News stories
From sources across the web
About Aimei Health Technology Co Ltd
CEO-
Employees0
Founded2023
Headquarters-
SectorCapital market
Website-
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
413.41K
41.60K
130.15K
250.59K
Operating expense
413.41K
41.60K
130.15K
250.59K
Total operating expenses
413.41K
41.60K
130.15K
250.59K
Operating income
-413.41K
-41.60K
-130.15K
-250.59K
Other non operating income
-
-
-
-
EBT including unusual items
184.66K
424.97K
352.02K
98.12K
EBT excluding unusual items
184.66K
424.97K
352.02K
98.12K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
184.66K
424.97K
352.02K
98.12K
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
598.08K
466.57K
482.17K
348.71K
Interest expense
-
-
-
-
Net interest expenses
598.08K
466.57K
482.17K
348.71K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer